YAHOO FINANCE CHARTBOOK

44 charts that explain markets and the economy right now

Munich - Delayed Quote EUR

Mydecine Innovations Group Inc (0NF0.MU)

0.0030

0.0000

(0.00%)

At close: January 28 at 8:05:41 AM GMT+1

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NF0), a leading biotechnology company dedicated to transforming mental health and addiction treatment, proudly announces the issuance of two Notice of Allowances by the United States Patent and Trademark Office (USPTO) for compounds from the Company’s MYCO-005 and MYCO-006 families. MYCO-005 Notice of Allowance: Aza-Substituted Psil

GlobeNewswire 11 months ago

MYCOF
Mydecine Innovations Group Announces Director Resignation

VANCOUVER, British Columbia, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE: 0NF0), a forefront biotechnology company dedicated to revolutionizing mental health and addiction treatment, announces that Neil Stevenson-Moore has resigned as a director of the Company. The Company would like to thank Mr. Stevenson-Moore for his contributions to the Company and wishes him well in this future endeavors. The Company

GlobeNewswire 11 months ago

MYCOF

Performance Overview

Return	0NF0.MU	S&P/TSX Composite index
YTD	+20.00%	+3.24%
1-Year	-84.62%	+20.33%
3-Year	-99.95%	+23.73%